Skip to main content
. 2022 Feb 8;53:77–82. doi: 10.1016/j.hrtlng.2022.02.003

Table 2.

Signs and symptoms of the patients on admission.

N (%) TOTAL (n = 52) Infected Group (n = 16)
Non-infected Group (n = 36)
PE (n = 4) Not PE (n = 12) PE (n = 11) Not PE (n = 25)
Fever 27 (51.9) 3 (75.0) 9 (75.0) 4 (36.4) 11 (40.7)
Dyspnea 28 (53.8) 2 (50.0) 6 (50.0) 5 (45.5) 15 (55.6)
Cough 18 (34.6) 2 (50.0) 4 (33.3) 4 (36.4) 9 (33.3)
Expectoration 5 (9.6) 0 (0.0) 1 (8.3) 1 (9.1) 4 (14.8)
Sore throat 3 (5.8) 0 (0.0) 3 (11.1)
Myalgia 9 (17.3) 1 (25.0) 2 (16.7) 4 (36.4) 3 (11.1)
Headache 2 (3.8) 1 (9.1) 1 (3.7)
Dizziness 6 (11.5) 0 (0.0) 2 (16.7) 0 (0.0) 4 (14.8)
Diarrhea 7 (13.5) 1 (25.0) 2 (16.7) 0 (0.0) 4 (14.8)
Chest pain 6 (11.5) 0 (0.0) 1 (8.3) 1 (9.1) 4 (14.8)
Malaise 21 (40.4) 2 (50.0) 7 (58.3) 3 (27.3) 9 (33.3)
Anosmia 2 (3.8) 1 (25.0) 1 (8.3)
Dysgeusia 3 (5.8) 1 (25.0) 1 (8.3) 0 (0.0) 1 (3.7)

*PE: Pulmonary thromboembolism.